WHO ICTRP trial
Comparison of the 3/5000 effectiveness, safety and brain protection of remazolam…
ChiCTR2100048602 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2100048602 |
|---|---|
| Public title | Comparison of the 3/5000 effectiveness, safety and brain protection of remazolam tosylate and midazolam in patients with moderate craniocerebral injury |
| Scientific title | Comparison of the 3/5000 effectiveness, safety and brain protection of remazolam tosylate and midazolam in patients with moderate craniocerebral injury |
| Primary sponsor | The First Affiliated Hospital of Zhengzhou University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | traumatic brain injury |
| Interventions | Group 1:remazolam tosylate;Group 2:midazolam |
| Registration date | Jul 11, 2021 |
| Target size | Group 1:30;Group 2:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: